Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept
Titel:
Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept
Auteur:
Favi, Evaldo Cresseri, Donata Perego, Marta Ikehata, Masami Iesari, Samuele Campise, Maria Rosaria Morello, William Testa, Sara Sioli, Viviana Mattinzoli, Deborah Longhi, Elena Del Gobbo, Alessandro Castellano, Giuseppe Ferraresso, Mariano